Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Lockheed Martin Corporation (LMT) vs Sanofi SA (SNY) Price & Performance

Lockheed Martin CorporationTrade

Price performance (Past 24H)

Key statistics

Lockheed Martin Corporation vs Sanofi SA — how do they compare? Lockheed Martin Corporation trades at $596.99 (market cap $137.96B), while Sanofi SA trades at $43.7 (market cap $104.30B). The key difference: Lockheed Martin Corporation is the larger of the two by market cap, and Sanofi SA pays the higher dividend (5.55%). Which is the better fit depends on your goals.

LMTSNY
Market Cap
$137.96B$104.30B
Sector
IndustrialsHealth
52-Week High
$676.70$52.34
52-Week Low
$431.56$41.33
Enterprise Value
$154.71B$124.19B
Dividend Yield
2.31%5.55%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Lockheed Martin Corporation

Lockheed Martin is the largest defense contractor globally and has dominated the Western market for high-end fighter aircraft since the F-35 program was awarded in 2001. Lockheed's largest segment is aeronautics, which is dominated by the massive F-35 program. Lockheed's remaining segments are rotary and mission systems, which is mainly the Sikorsky helicopter business.

Read more on LMT

About Sanofi SA

Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 10% of total sales, but profits are shared with Regeneron. About 30% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.

Read more on SNY